Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03739372 · ClinicalTrials.gov registry record · NA
Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma
A NA study of Cancer and Glioblastoma, sponsored by University of California, San Francisco.
- Active
- Registry status
- NA
- Development phase
- 44
- Enrollment target
- 12
- Study locations
NCT03739372 is a NA study of Cancer and Glioblastoma that is active but no longer recruiting, run by University of California, San Francisco. The registered enrollment target is 44 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 12 study locations across 11 states.
The verdict
NCT03739372, a NA study of Cancer and Glioblastoma, is active but no longer recruiting, sponsored by University of California, San Francisco.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
- 12
- Study locations
Study Summary
This is a 2 strata pilot trial within the Pacific Pediatric Neuro-Oncology Consortium (PNOC). The study will use a new treatment approach based on each patient's tumor gene expression, whole-exome sequencing (WES), targeted panel profile (UCSF 500 gene panel), and RNA-Seq. The current study will test the efficacy of such an approach in children with High-grade gliomas HGG.
Conditions Studied
Interventions
- OTHER Specialized tumor board recommendation
Study Locations (12)
California
- University of California, San Diego Rady Children's Hospital - San Diego
- University of California, San Francisco - San Francisco
District of Columbia
- Children's National Medical Center - Washington D.C.
Florida
- University of Florida - Gainesville
Illinois
- Ann & Robert H. Lurie Children's Hospital of Chicago - Chicago
Maryland
- Johns Hopkins University - Baltimore
Minnesota
- Children's Hospitals and Clinics of Minneapolis - Minneapolis
Missouri
- Washington University - St Louis
Ohio
- Nationwide Children's Hospital - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2018-11-28 |
| Est. Completion | 2027-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03739372
The ClinicalTrials.gov registry entry for NCT03739372 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 8 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Specialized tumor board recommendation is the first listed.
NCT03739372 reports 12 study locations spanning 11 distinct geographic areas - top geographies include California, District of Columbia, Florida.
Frequently Asked Questions
What is clinical trial NCT03739372 about?
NCT03739372 is a clinical study titled "Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma". This is a 2 strata pilot trial within the Pacific Pediatric Neuro-Oncology Consortium (PNOC). The study will use a new treatment approach based on each patient's tumor gene expression, whole-exome sequencing (WES), targeted panel profile (UCSF 500 gene panel), and RNA-Seq. The current study will te...
What is the current status of trial NCT03739372?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 44 participants. The study started on 2018-11-28. Estimated completion is 2027-01-01.
What conditions does trial NCT03739372 study?
This clinical trial studies the following conditions: Cancer, Glioblastoma, Glioma, Pediatric Cancer, Astrocytoma.
What interventions are being tested in trial NCT03739372?
The interventions under investigation include: Specialized tumor board recommendation (OTHER).
Who is sponsoring clinical trial NCT03739372?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03739372 being conducted?
This trial has 12 study locations across California, District of Columbia, Florida, Illinois, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.